Normal view MARC view ISBD view

Phase I/II study of trastuzumab, pertuzumab, palbociclib and fulvestrant in patients with HER2-positive and hormone receptor positive metastatic breast cancer

Phase I/II study of trastuzumab, pertuzumab, palbociclib and fulvestrant in patients with HER2-positive and hormone receptor positive metastatic breast cancer - 2016

Index Terms--Curriculum Objective:
Poster presented at

Print
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)